Zobrazeno 1 - 10
of 409
pro vyhledávání: '"heterologous prime-boost"'
Autor:
Li D, Bian L, Cui L, Zhou J, Li G, Zhao X, Xing L, Cui J, Sun B, Jiang C, Kong W, Zhang Y, Chen Y
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 8029-8042 (2024)
Dongdong Li,1 Lijun Bian,1 Lili Cui,2 Jingying Zhou,1 Gaotian Li,1 Xiaoyan Zhao,1 Liao Xing,1 Jiaxing Cui,1 Bo Sun,1 Chunlai Jiang,1,3,4 Wei Kong,1,3,4 Yong Zhang,1,3,4 Yan Chen1,3,4 1National Engineering Laboratory for AIDS Vaccine, School of Life S
Externí odkaz:
https://doaj.org/article/07528551113b4c769cc33f13f20543bb
Autor:
Hiroki Uchiyama, Toshifumi Kudo, Takehiro Yamaguchi, Nozomu Obana, Kenji Watanabe, Kimihiro Abe, Hidetaka Miyazaki, Masanori Toyofuku, Nobuhiko Nomura, Yukihiro Akeda, Ryoma Nakao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThere is a growing interest in development of novel vaccines against respiratory tract infections, due to COVID-19 pandemic. Here, we examined mucosal adjuvanticity and the mucosal booster effect of membrane vesicles (MVs) of a novel probioti
Externí odkaz:
https://doaj.org/article/f9ac0a5cea9a47029ede47ea185d23ea
Autor:
Szu-Ting Huang, Yu-Shan Huang, Wang-Da Liu, Sung-Ching Pan, Hsin-Yun Sun, Chia-En Lien, Charles Chen, Szu-Min Hsieh
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 11, Pp 1165-1173 (2023)
Background/Purpose: MVC-COV1901 is a protein vaccine based on the same SARS-CoV-2 strain used in mRNA vaccine mRNA-1273. Data are lacking on immunogenicity and safety of MVC-COV1901 as heterologous boost for people already received one dose of mRNA-1
Externí odkaz:
https://doaj.org/article/eeee38274f504e0eacc3fd5a4dcf4840
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/bad3e020a0af4ba5821ea92217e0ddc8
Autor:
Niko Kohmer, Shivana Stein, Barbara Schenk, Katharina Grikscheit, Melinda Metzler, Holger F. Rabenau, Marek Widera, Eva Herrmann, Sabine Wicker, Sandra Ciesek
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 166-175 (2023)
Objectives: Regarding reactogenicity and immunogenicity, heterologous COVID-19 vaccination regimens are considered as an alternative to conventional immunization schemes. Methods: Individuals receiving either heterologous (ChAdOx1-S [AstraZeneca, Cam
Externí odkaz:
https://doaj.org/article/71587574b93e4fd791db7567f3c3fe3d
Autor:
Vasilis C. Pliasas, Peter J. Neasham, Maria C. Naskou, Rachel Neto, Philip G. Strate, J. Fletcher North, Stephen Pedroza, Strickland D. Chastain, Ian Padykula, S. Mark Tompkins, Constantinos S. Kyriakis
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Influenza A viruses (IAVs) pose a significant threat to both human and animal health. Developing IAV vaccine strategies able to elicit broad heterologous protection against antigenically diverse IAV strains is pivotal in effectively controlling the d
Externí odkaz:
https://doaj.org/article/63c844d27d8246f6856e46142c485992
Autor:
Leyla Sharifi Aliabadi, Manoochehr Karami, Maryam Barkhordar, Seyed Saeed Hashemi Nazari, Amir Kavousi, Mohammad Ahmadvand, Mohammad Vaezi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background/PurposeOptimizing vaccine efficacy is of particular concern in patients undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an inadequate immune response to primary SARS-CoV-2 vaccination. This investigation aimed
Externí odkaz:
https://doaj.org/article/c4d580ed5ea7477ca3d3f356d5f6a89e
Publikováno v:
Infectious Disease Reports, Vol 14, Iss 4, Pp 537-546 (2022)
Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA, adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection. A prime-boost regimen (administration of two doses) is recommended to induce an
Externí odkaz:
https://doaj.org/article/0f94c95255014b5a822c4d128ad0ef2b
Publikováno v:
Veterinary Research, Vol 53, Iss 1, Pp 1-15 (2022)
Abstract Heterologous prime-boost vaccination with experimental or commercial influenza vaccines has been successful in various animal species. In this study, we have examined the efficacy of alternating 3 different European commercial swine influenz
Externí odkaz:
https://doaj.org/article/d8db9626f77b4b77b1f7eff3bfa0111c
Autor:
Xingxing Li, Jingjing Liu, Wenjuan Li, Qinhua Peng, Miao Li, Zhifang Ying, Zelun Zhang, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Guangzhi Yue, Yue Suo, Jianhui Nie, Weijin Huang, Jia Li, Yuhua Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or 2019-nCoV) variants has been associated with the transmission and pathogenicity of COVID-19. Therefore, exploring the optimal immunisation strategy to improve the
Externí odkaz:
https://doaj.org/article/ed4ce87f1c364ac099e43b924d0726bd